Basel's reputation in healthcare and technology is backed by a strong group of investors. These firms are consistently placing bets on early-stage startups changing the industry.

You'll find established names like Novartis Venture Fund, with over 70 exits, alongside newer funds like Kickfund that have quickly made dozens of investments. It's a healthy mix of experience and fresh energy for founders seeking capital.

Below is our list of the best 3 VC firms in Basel.

Failory's Top 3 Picks

Kickfund Logo

Kickfund invests in Swiss deep-tech startups at the pre-seed and seed stages, exclusively backing winners of the Venture Kick competition. The fund acts as a co-investor during early equity rounds to help grow the national innovation ecosystem and give Swiss startups global visibility.

Year Founded2022
Founders—
Investment StageConvertible Note, Early Stage, Seed
Nº of Investments37 (7 as Lead Investor)
Nº of Exits1
Contactinfo@kickfund.ch

As one of Europe's leading venture capital firms, BioMedPartners directs private equity and mezzanine financing toward early and mid-stage healthcare and human life science companies. They concentrate on ventures in pharmaceuticals, biotechnology, diagnostics, and medical technology, guiding them from initial funding rounds to later stages of expansion.

Year Founded2003
FoundersGerhard Ries
Investment StageEarly Stage, Late Stage
Nº of Investments84 (27 as Lead Investor)
Nº of Exits21 (8 IPO'd)
Contactinfo@biomedvc.com / +41 61 270 3500

As the venture arm of global healthcare company Novartis, they invest in early-stage life sciences and biotech companies developing novel therapeutics and platforms to address unmet medical needs. This strategic fund acts as a long-term partner, providing deep scientific expertise and substantial capital to build companies from the ground up, with a portfolio that includes biotech pioneers like Alnylam.

Year Founded1996
FoundersArgeris Karabelas
Total Funding$720M
IndustriesLife Sciences, Biotech
Investment StageEarly Stage, Late Stage, Post-Ipo, Seed
Nº of Investments267 (73 as Lead Investor)
Nº of Exits75 (35 IPO'd)
Top Portfolio StartupsEnterprise Therapeutics, Expansion Therapeutics, Immunitas
Contactklydon@sosei.com / 877 280 2296